Paper20935652
Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors.
Anliker B and 17 others. Nat Methods, 2010. Cited by 124 papers, by iCite.
Cite this record
ConductScience Library. Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors. Papers, record 20935652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20935652
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Endothelial Cells | Major topic |
| Gene Transfer Techniques | Major topic |
| Genetic Vectors | Major topic |
| Hematopoietic Stem Cells | Major topic |
| Lentivirus | Major topic |
| Neurons | Major topic |
| AC133 Antigen | |
| Animals | |
| Antigens, CD | |
| Antigens, CD20 | |
| Cells, Cultured | |
| Glycoproteins | |
| Hippocampus | |
| Humans | |
| Mice | |
| Mice, Inbred C57BL | |
| Peptides | |
| Receptors, AMPA |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15063787 | Isolation of endothelial cell-specific human antibodies from a novel fully synthetic scFv library. | Biochem Biophys Res Commun | 2004 | https://conductscience.org/library/papers/15063787 | PubMed |
| 2 | 15905858 | Chronic gene delivery of interferon-inducible protein 10 through replication-competent retrovirus vectors suppresses tumor growth. | Cancer Gene Ther | 2005 | https://conductscience.org/library/papers/15905858 | PubMed |
| 3 | 7954815 | Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA. | Cell | 1994 | https://conductscience.org/library/papers/7954815 | PubMed |
| 4 | 19198560 | Measles virus receptors. | Curr Top Microbiol Immunol | 2009 | https://conductscience.org/library/papers/19198560 | PubMed |
| 5 | 17406580 | Stereotaxic gene delivery in the rodent brain. | Nat Protoc | 2006 | https://conductscience.org/library/papers/17406580 | PubMed |
| 6 | 15711560 | Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection. | Nat Med | 2005 | https://conductscience.org/library/papers/15711560 | PubMed |
| 7 | 19609263 | Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. | Nat Rev Genet | 2009 | https://conductscience.org/library/papers/19609263 | PubMed |
| 8 | 15549107 | Identification of human brain tumour initiating cells. | Nature | 2004 | https://conductscience.org/library/papers/15549107 | PubMed |
| 9 | 20372106 | Transduction of human primitive repopulating hematopoietic cells with lentiviral vectors pseudotyped with various envelope proteins. | Mol Ther | 2010 | https://conductscience.org/library/papers/20372106 | PubMed |
| 10 | 16409120 | Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications. | Hum Gene Ther | 2006 | https://conductscience.org/library/papers/16409120 | PubMed |
| 11 | 9916792 | Generalized lacZ expression with the ROSA26 Cre reporter strain. | Nat Genet | 1999 | https://conductscience.org/library/papers/9916792 | PubMed |
| 12 | 18074400 | Efficient targeted transduction of primary human endothelial cells with dual-targeted lentiviral vectors. | J Gene Med | 2008 | https://conductscience.org/library/papers/18074400 | PubMed |
| 13 | 10691975 | Use of proteoliposomes to generate phage antibodies against native AMPA receptor. | Eur J Biochem | 2000 | https://conductscience.org/library/papers/10691975 | PubMed |
| 14 | 14675410 | Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors. | Br J Haematol | 2004 | https://conductscience.org/library/papers/14675410 | PubMed |
| 15 | 18067118 | CD133: molecule of the moment. | J Pathol | 2008 | https://conductscience.org/library/papers/18067118 | PubMed |
| 16 | 7494260 | Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. | J Virol | 1995 | https://conductscience.org/library/papers/7494260 | PubMed |
| 17 | 19075628 | Strategies for targeting lentiviral vectors. | Curr Gene Ther | 2008 | https://conductscience.org/library/papers/19075628 | PubMed |
| 18 | 10203685 | Hypersensitivity to seizures in beta-amyloid precursor protein deficient mice. | Cell Death Differ | 1998 | https://conductscience.org/library/papers/10203685 | PubMed |
| 19 | 15694831 | AC133/CD133/Prominin-1. | Int J Biochem Cell Biol | 2005 | https://conductscience.org/library/papers/15694831 | PubMed |
| 20 | 11248119 | Genetically altered AMPA-type glutamate receptor kinetics in interneurons disrupt long-range synchrony of gamma oscillation. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11248119 | PubMed |
Cited by83
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 124 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42785298 | Systemic delivery of phagocytosis-shielded retroviral vectors enables in vivo HSC gene therapy for sickle cell disease. | Cell Stem Cell | 2026 | https://conductscience.org/library/papers/42785298 | PubMed |
| 41942453 | In vivo CAR T cell generation using retargeted and functionalized lentiviral vectors with reduced immunogenicity. | Nat Commun | 2026 | https://conductscience.org/library/papers/41942453 | PubMed |
| 41817927 | In Vivo T-Cell Engineering: Revolution in Delivery Strategies and Clinical Translation. | BioDrugs | 2026 | https://conductscience.org/library/papers/41817927 | PubMed |
| 41751878 | In Vivo CAR-T Therapies-A New Era of Programmable Immunity. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41751878 | PubMed |
| 41028170 | In vivo chimeric antigen receptor (CAR)-T cell therapy. | Nat Rev Drug Discov | 2026 | https://conductscience.org/library/papers/41028170 | PubMed |
| 40573393 | Progress in Pseudotyping Lentiviral Vectors Towards Cell-Specific Gene Delivery In Vivo. | Viruses | 2025 | https://conductscience.org/library/papers/40573393 | PubMed |
| 39329149 | Cell-targeted gene modification by delivery of CRISPR-Cas9 ribonucleoprotein complexes in pseudotyped lentivirus-derived nanoparticles. | Mol Ther Nucleic Acids | 2024 | https://conductscience.org/library/papers/39329149 | PubMed |
| 39272178 | In vivo CAR T cell therapy against angioimmunoblastic T cell lymphoma. | J Exp Clin Cancer Res | 2024 | https://conductscience.org/library/papers/39272178 | PubMed |
| 39113357 | T-cell specific in vivo gene delivery with DART-AAVs targeted to CD8. | Mol Ther | 2024 | https://conductscience.org/library/papers/39113357 | PubMed |
| 37646032 | CD62L as target receptor for specific gene delivery into less differentiated human T lymphocytes. | Front Immunol | 2023 | https://conductscience.org/library/papers/37646032 | PubMed |
| 37550965 | CD90-targeted lentiviral vectors for HSC gene therapy. | Mol Ther | 2023 | https://conductscience.org/library/papers/37550965 | PubMed |
| 37446085 | Unmasking the Deceptive Nature of Cancer Stem Cells: The Role of CD133 in Revealing Their Secrets. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37446085 | PubMed |
| 36585761 | Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors. | Cancer Commun (Lond) | 2023 | https://conductscience.org/library/papers/36585761 | PubMed |
| 36298713 | Adapter-Mediated Transduction with Lentiviral Vectors: A Novel Tool for Cell-Type-Specific Gene Transfer. | Viruses | 2022 | https://conductscience.org/library/papers/36298713 | PubMed |
| 36015231 | Lentiviral Vectors for Ocular Gene Therapy. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36015231 | PubMed |
| 35598048 | Precision medicine: In vivo CAR therapy as a showcase for receptor-targeted vector platforms. | Mol Ther | 2022 | https://conductscience.org/library/papers/35598048 | PubMed |
| 34729380 | Lentiviral and adeno-associated vectors efficiently transduce mouse T lymphocytes when targeted to murine CD8. | Mol Ther Methods Clin Dev | 2021 | https://conductscience.org/library/papers/34729380 | PubMed |
| 34713246 | Baboon Envelope Pseudotyped "Nanoblades" Carrying Cas9/gRNA Complexes Allow Efficient Genome Editing in Human T, B, and CD34+ Cells and Knock-in of AAV6-Encoded Donor DNA in CD34+ Cells. | Front Genome Ed | 2021 | https://conductscience.org/library/papers/34713246 | PubMed |
| 34638603 | Tagging and Capturing of Lentiviral Vectors Using Short RNAs. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34638603 | PubMed |
| 34198789 | An Update on the HIV DNA Vaccine Strategy. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34198789 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| KRT20 | 54474 | PubTator's text mining | https://conductscience.org/library/genes/54474 | NCBI Gene |
| PROM1 | 8842 | PubTator's text mining | https://conductscience.org/library/genes/8842 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20935652
GET https://conductscience.org/api/papers/v1/20935652/references?page=2